1315 Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Nu Tekbiosciencesnu-tekbiosciences.cominMay 2023
Nu-Tek BioSciences manufactures plant- and yeast-based cell culture nutrients and fermentation supplements for pharmaceutical and biotechnology companies.
Advanced ManufacturingBiotechImpact & Social GoodNew MaterialsMinnetonka, US
Thomas Yezzi(Founder & CEO)Kent McCoy(Chief Financial Officer of the Issuer)in
Co-investorsAgent Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.